Nobel Prize–winning Turkish scientist Professor Aziz Sancar and his research team have achieved a significant breakthrough in an experimental study on glioblastoma, one of the most aggressive forms of brain cancer. According to the findings, tumors in mice were completely eliminated within just 23 days using a laboratory-based treatment approach.
Why the Findings Matter
As part of the study, researchers applied a treatment combining a widely used chemotherapy drug with a laboratory compound known as EdU. This combination was found to completely eradicate glioblastoma tumor cells in mice without causing damage to healthy brain tissue. The results point to an effect that has not previously been observed in glioblastoma research, marking a potentially important advance in the field.
How the Clinical Process Will Progress
Sancar and his team emphasized that while the results have attracted considerable attention within the scientific community, the findings have so far been obtained only in animal models. They underlined that extensive clinical trials are required to determine whether the approach can be used safely and effectively in humans. According to the researchers, this process is expected to take at least two more years.
The study opens the door to a potential new treatment strategy in the fight against glioblastoma, a deadly brain tumor for which current treatment options remain limited. For both the scientific community and patient groups, the findings are being described as promising, offering cautious optimism for future advances.
